Patients with high thyroid hormone levels before surgery were given stronger medications like iodine, lithium, and steroids to reduce surgical risk, showing that doctors took extra steps to protect them even when they couldn't normalize thyroid levels.
Claim Context
Patients with preoperative thyrotoxicosis undergoing thyroidectomy received more intensive preoperative pharmacological preparation, including Lugol’s solution, lithium, and hydrocortisone, compared to euthyroid patients, indicating that clinicians actively managed thyrotoxicosis despite not achieving euthyroidism.
“The thyrotoxic group had higher Burch–Wartofsky Point Scale scores, lower thyrotropin levels, elevated thyrotropin receptor antibody titers, increased alanine aminotransferase levels, and more frequent use of Lugol's solution, lithium, and hydrocortisone preoperatively.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether specific preoperative agents (e.g., Lugol’s, lithium) consistently reduce complications in thyrotoxic Graves' patients across diverse settings.
A systematic review and meta-analysis of all studies reporting preoperative pharmacological regimens in Graves' thyroidectomy, comparing complication rates between patients receiving Lugol’s, lithium, corticosteroids, or combinations versus none, with subgroup analysis by thyroid hormone severity.
An RCT could determine whether adding lithium or hydrocortisone to standard care reduces complications in thyrotoxic patients undergoing thyroidectomy.
A double-blind RCT of 150 thyrotoxic Graves' patients undergoing thyroidectomy, randomized to standard care (beta-blockers + Lugol’s) versus standard care plus lithium (300 mg TID) and hydrocortisone (100 mg IV pre-op), with primary outcome: composite complication rate within 7 days.
A prospective cohort could assess whether the intensity of preoperative pharmacological preparation correlates with complication rates in thyrotoxic patients.
A prospective cohort study of 300 thyrotoxic Graves' patients undergoing thyroidectomy, prospectively recording use and timing of Lugol’s, lithium, hydrocortisone, and beta-blockers, and correlating with complication rates using multivariable analysis.
A case-control study could determine whether patients who received intensive preoperative drugs were less likely to develop complications.
A matched case-control study of 80 patients with complications and 160 without, matched for age, goiter size, and TSH, assessing whether use of lithium, hydrocortisone, or Lugol’s was more frequent in the non-complication group.
A cross-sectional study could describe the frequency of pharmacological agents used in thyrotoxic patients undergoing surgery, but cannot link them to outcomes.
A single-center cross-sectional analysis of 100 thyrotoxic Graves' patients undergoing thyroidectomy, recording preoperative use of Lugol’s solution, lithium, hydrocortisone, and beta-blockers, with no outcome follow-up.